Abstract Little is known about adipocyte metabolism during aging process and whether this can influence body fat redistribution and systemic metabolism. To better understand this phenomenon, two animal groups were studied: young-14 weeks old-and middleaged-16 months old. Periepididymal (PE) and subcutaneous (SC) adipocytes were isolated and tested for their capacities to perform lipolysis and to incorporate and [9,10(n)-3 H]-oleic acid into lipids. Additionally, the morphometric characteristics of the adipose tissues, glucose tolerance tests, and biochemical determinations (fasting glucose, triglycerides, insulin) in blood were performed. The middle-aged rats showed adipocyte (PE and SC) hypertrophy and glucose intolerance, although there were no significant changes in fasting glycemia and insulin. Furthermore, PE tissue revealed elevated rates (+50 %) of lipolysis during beta-adrenergic-stimulation. There was also an increase (+62 %) in the baseline rate of glucose incorporation into lipids in the PE adipocytes, while these PE cells were almost unresponsive to insulin stimulation and less responsive (a 34 % decrease) in the SC tissue. Also, the capacity of oleic acid esterification was elevated in baseline state and with insulin stimulus in the PE tissue (+90 and 82 %, respectively). Likewise, spontaneous incorporation of lactate into lipids in the PE and SC tissues was higher (+100 and 11 %, respectively) in middle-aged rats. We concluded that adipocyte metabolism of middle-aged animals seems to strongly favor cellular hypertrophy and increased adipose mass, particularly the intra-abdominal PE fat pad. In discussion, we have interpreted all these results as a metabolic adaptations to avoid the spreading of fat that can reach tissues beyond adipose protecting them against ectopic fat accumulation. However, these adaptations may have the potential to lead to future metabolic dysfunctions seen in the senescence.
undergoes intense redistribution along the aging process. In middle age, the increase of adiposity is particularly present in intra-abdominal fat deposits, while in old age, the loss of adipose mass is predominantly subcutaneous (Cartwright et al. 2007; Kirkland et al. 2002) .
Metabolically, adipose tissue is important due to its huge capacity to store energy that can be thereafter mobilized as needed. Nevertheless, what appears to be an ordinary balance between deposition and mobilization of intracellular fat (lipogenesis against lipolysis) can actually influence systemic metabolism and, along with its endocrine capacity, confers to adipose tissue the active functional role of regulating energy metabolism.
Substrate cycles are important means of metabolic regulation (Newsholme 1980) . The triglyceride/fatty acid cycle, for example, was considered a Bfutile^cycle because it did not appear to possess any obvious significance (Forest et al. 2003; Cadoudal et al. 2005) . However, it is now known that adipocyte way to deal with their fat stores (i.e., by hydrolyzing and reconstituting triglycerides) determines the rate at which fatty acids are released into the blood stream, influencing the ectopic deposit of fat and, consequently, impacting systemic sensitivity to insulin and glucose oxidation (Randle et al. 1994; Forest et al. 2003; Langin 2011) .
Fatty acids necessary for triglyceride synthesis can come from lipoproteins in the blood stream and/or from the intracellular environment. This process of triglyceride reconstitution is called re-esterification. Glucose supplies carbons to glycerol-3-phosphate and also to fatty acid synthesis, a process called de novo lipogenesis. On the other hand, metabolites such as pyruvate and lactate are important substrates for glyceroneogenesis, in which glycerol-3-phosphate derives from others precursors, other than glucose or glycerol. All these metabolic routes can influence the triglyceride/fatty acid cycle and systemic metabolism (Abel et al. 200; Reshef et al. 2003) .
Although the anatomic and morphological changes brought on by aging have been widely reported (Tchkonia et al. 2010; Tchkonia et al. 2013) , little is known about the way adipocytes handles above cites metabolites during aging and whether this can influence body fat redistribution and systemic metabolism. Based on this, the main goal of the present work was to compare metabolic pathways (lipolysis and lipogenesis) of middle-aged and young rat adipocytes. We sought, then, to identity the phenomena involved in this process, aiming at an initial comprehension of metabolic pathways and establishing the bases for a deeper understanding of this issue.
Material and methods

Animals
Male Wistar rats from the Animal Resources Center of the Institute of Biomedical Sciences of the University of São Paulo were used in the experiments. The rats were housed in individual cages with free access to water and food (balanced chow pellet diet, Nuvilab CR1, Nuvital SA, Colombo, Brazil) and kept on an inverted 12:12-h light-dark cycle (lights on at 6:00 p.m.). The animals were divided into 2 groups: young-14 weeks old-and middle-aged-16 months old.
Oral glucose tolerance test
To determine the blood glucose curve after oral glucose overload, after 12 h of fasting, young (n=8) and middleaged (n=6) rats received an oral glucose load (75 mg/ 100 g b.w.) by gavage. Blood glucose was measured by a glucometer (OneTouch Ultra, Johnson & Johnson), at different times: 0 (pregavage) and 5, 15, 30, 60, and 90 min after glucose administration.
Euthanasia and animal biometric determinations
Young (n=5) and middle-aged (n=8) were fasted for 12 h and destined for all subsequent tests. Animals were preanesthetized with thiopental sodium (50 μg/ g b.w.). Weight and nasal-anal lengths were measured to Lee obesity index calculation ( 3 √body weight/ naso-anal length) × 1000 according to Plocher and Powley (1977) . Then, euthanasia was performed by decapitation. The Ethical Committee for Animal Research of the Institute of Biomedical Sciences of the University of Sao Paulo approved all of the experimental procedures. Blood serum was collected for biochemical and hormonal analyses, and fat pads from subcutaneous (SC) and peri-epididymal (PE) regions were weighed.
Adipocyte isolation
The PE and SC fat pad (1 g) were minced with fine scissors and digested at 37°C in 4 ml of EHB buffer 1 ( E a r l e ' s s a l t s , 2 5 m M H E P E S [ N -2 -hydroxyethylpiperazine-N-2-ethanesulfonic acid] and 4 % BSA [bovine serum albumin]), pH 7.4, containing collagenase type I (1.25 mg/mL) from Worthington Biochemical Corporation (New Jersey, NY, USA). The adipocytes were then isolated according to Rodbell (1964) . The isolated adipocytes (7-8×10 5 cells/mL) were suspended in EHB buffer (Earle's salts, 20 mM HEPES, 1 % bovine serum albumin, 2 mM sodium pyruvate, and 4.8 mM sodium bicarbonate), pH 7.4, at 37°C. Cell size and number were determined as previously described by Di Girolamo et al. (1971 (10 nM) (except for the lactate assay). These samples were then incubated (final volume=500 μL) for 1 h at 37°C in a water bath. The tubes had a rubber stopper, and the atmosphere inside was enriched with CO 2 (5 %)/O 2 (95 %). At the end of this incubation, for [9,10(n)-3 H] oleic acid assay, 800 μL of silicone oil was added followed by 1-min centrifugation in order to collect the suspended cells (and to get rid of labeled fatty acids exceeding in the medium), and thus, in all the three assays, the final reaction mixture was treated with 2.5 mL of Dole's reagent (isopropanol/n-heptane/sulfuric acid, 4:1:0.25) for cell lipid extraction. The results were expressed as nmol/10 6 cells/h.
Measurement of lipolysis
The rates of basal and isoproterenol-stimulated lipolysis were measured in the isolated adipocytes according to the following protocol: 40-μL aliquots of cell suspension (EHB buffer containing 5 mM of glucose) were transferred to microtubes (0.6 mL) and incubated with 0.3 mM adenosine for 30 min. Next, 20 μL of adenosine deaminase (ADA, 0.2 U/mL in EHB buffer, pH 7.45) from Sigma-Aldrich (USA) was added for 30 min at 37°C to allow the adenosine to degrade (16). After this period, the cells were incubated for 60 min at 37°C with or without 10 μL of isoproterenol ([−]-Isoproterenol [+ ]-bitartrate salt) from Sigma-Aldrich (USA) in final concentration of 1 μM and a total volume of 200 μL.
At the end of the incubation, the reaction was stopped by transferring the tubes to an ice bath, followed by centrifugation at 7000 rpm for 5 min at 4°C to isolate the cells in the reaction medium. The amount of glycerol released from adipocytes into the incubation medium was determined using an enzymatic-colorimetric method (Free Glycerol Determination Kit) from Sigma-Aldrich (USA) and used as an index of the lipolysis rate. The results were expressed in nmol/10 6 cells/h.
Biochemical and hormonal measurements in plasma
Triacylglycerol (TAG-Bioclin K005) and total cholesterol (TC-Labtest 76-2) were determined using enzymatic methods with commercial kits. Insulin levels were determined by radioimmunoassay (RI-13K Linco Research, Inc.). As described in Matthews et al. (1985) , we calculated the homeostasis model of assessment-insulin
.5, and HOMA-beta-cell function index (20×insulin/glucose)−3.5.
Statistical analysis
The means±SEM of the individual data from each group were obtained and analyzed using a Student's Bt^test, unpaired and parametric. For nonparametric data, Mann-Whitney rank sum test was used. The upper limit of significance for rejection of the null hypothesis was established at 5 % (p<0.05). Table 1 shows that middle-aged animals had a greater total body weight. Nonetheless, through the Lee index, we demonstrated that middle-aged animals' higher body weight was compatible with their size and did not result from severe obesity. However, the middle-aged animals had a greater percentage of PE fat, but not SC inguinal fat. On the other hand, the adipocytes from both deposits presented greater volume during middle age (Fig. 1) , a tendency that was not followed by an estimated increase in the cell number of the fat depots (Table 1) , indicating cellular hypertrophy of the tissues that were studied.
Results
Somatometric characteristics of animals
Metabolic characteristics (Fig. 2) , the changes were statistically significant, revealing a certain degree of glucose intolerance in middle-aged animals.
Lipolytic capacity of isolated adipocytes
Figure 3 details the differences of lipolytic capacity in adipocytes from the PE and SC fat deposits. PE adipocytes of middle-aged rats showed greater response to the β-adrenergic agonist isoproterenol; this was not replicated in SC adipocytes.
Incorporation of D-[U-
14 C] glucose in isolated adipocytes of middle-aged rats
In Fig. 4 , the rates of D-[U-14 C]-glucose incorporated into lipids were determined, from which the lipogenic capacity of the PE and SC adipocytes was evaluated. Without insulin, PE adipocytes of middle-aged rats exhibited a greater ability to synthesize lipids than the PE adipocytes of young rats, while insulin did not increase Figure 5 shows that, in middle-aged rats, the PE adipocytes had a greater ability to esterify the [ In Fig. 6 , it is worthy to note that even without hormonal stimulation, cells from both adipose depots of middleaged rats exhibited more intense rates of incorporation of lactate into lipids than did the adipocytes from the same fat depots of young rats.
14 C] glucose in the glycerol and fatty acid moieties of TAG in isolated adipocytes Data on Table 2 reports the proportional amounts (%) of glucose directed toward the fatty acyl or glycerol moieties in PE and SC adipocytes. In SC cells of middle-aged rats, there was a preferential steering of D-[U- Fig. 2 Oral glucose tolerance test. Young (n=8) and middleaged (n=6) rats were submitted to an oral glucose load as described in BMaterial and methods.^As can be seen, middle-aged rats showed a worsening of glucose tolerance. This is seen in the small figure depicted on what occurred in the young animals. In this last case, the substrate proportion directed to the fatty acyl moiety was smaller.
Discussion
This study was performed in order to get an overview of the metabolic changes that take place in adipocytes from middle-aged rats in an attempt to understand their influence on systemic metabolism and the possible repercussions in disorders like obesity, type 2 diabetes mellitus, and metabolic syndrome that are very common with the aging process. Here, we focused on metabolic changes of the adipocytes in middle-aged rats. Furthermore, we observed that adipocytes from two different depots present distinct peculiar alterations which may be associated with the expansion of fat mass and the regulation of systemic metabolism. First, we assessed the changes in the lipolytic capacity in middle-aged rats. Cell size has been shown to be a determining factor of responsiveness to lipolytic agents, since larger cells exhibit a greater propensity toward lipolysis (Reynisdottir et al. 1997; Tchernof and Després 2013) . Nevertheless, despite the fact that the middleaged animals presented a consistent adipocyte hypertrophy in both fat pads, only the PE adipocytes displayed a lipolytic activity that was more pronounced than the same cells of young animals. In fact, a previous work reported that adipose cells from intra-abdominal (n=5) and middle-aged (n=8) rats were incubated for 60 min at 37°C in absence (spontaneous) and in presence of insulin 10 nM. ([9,10(n)- 3 H] oleic acid, 1850 Bq) was added to the incubation medium at the beginning of the test. At the end, adipocyte lipid content was extracted, and the radioactivity incorporated was determined as described. Student's Bt^test, unpaired and parametric was used to analyze results. *p < 0.05 (middle-aged vs young, for insulin-stimulated PE adipocytes) deposits usually exhibit a greater lipolytic capacity than SC cells during diet-induced obesity (Gaidhu et al. 2010) . It is worth observing that the heightened lipolytic capacity of intra-abdominally located fat stores is a feature of human obesity and metabolic syndromes. Increased visceral adipose tissue lipolitic activity raises the flow of free fatty acids in mesenteric circulation through the portal-hepatic system increasing risk ectopic fat deposition and of lipotoxicity in the liver. Once this condition is established, a local inflammation and an onset of insulin resistance in liver predispose systemic dysfunctions, as glucose intolerance and insulin resistance (for a better review of this issue, see Nielsen et al. 2004; Tchernof and Després 2013) .
In our study, middle-aged rats did not present relevant changes in parameter measurements, such as fasting insulin, glucose, TAG, and total cholesterol or HOMA indexes (insulin resistance and beta-cell function), leading us to believe that no systemic dysfunction have developed, at least during fasting state. On the other hand, impaired glucose tolerance was found after a glucose overload featuring what could be the onset of age-induced metabolic dysfunctions, possibly induced by increased adipose mass (which affects the adipokine secretion pattern) and its lipolytic capacity (Carrascosa et al. 2011) .
The data from tests of lipogenic capacity reinforce the impression that fat mass development and expansion in middle-aged rats is a process in course, since (at many points) there was an increased response when three different substrates were used to assess lipogenesis. However, it has been proposed that lipid incorporation in adipose tissue brings some beneficial effects to the animals since it results in a prevention of nutrientinduced toxicity (Nolan et al. 2015) . In this context, metabolic flux may be directed toward adipose tissue in the initial stages of glucose intolerance and insulin resistance and has been considered a trigger of fat gain and obesity, since this tissue becomes the frequent destination for metabolic substrates (Prada et al. 2005) . Hypothetically, directing these substrates to the adipose tissue results in initial benefits for two reasons: first, it prevents the increase in glycemia and lipidemia, which brings toxicity and metabolic dysfunction to other tissues; and second, because there is a very large capacity for storing these substrates in the form of triglycerides, adipose tissue works as a metabolic buffer that prevents the potentially harmful effects of lipotoxicity caused by ectopic fat accumulation. In this sense, metabolic adipose tissue recovery (induced by the PPARγ agonist Pioglitazone) is associated with a better improvement in an experimental model of streptozotocin-induced diabetes than drugs which does not induce adipose metabolic recovery (Takada et al. 2008) . Still, in a transgenic model of increased PEPCK enzyme, in which an increased re-esterification of fatty acids occurs due to the greater availability of glycerol synthesized from substrates such as lactate, obesity is induced; however, it is exempted from insulin resistance (Franckhauser et al. 2002) . In addition, the control of adipose tissue de novo lipogenesis in another transgenic model exerts beneficial effects on systemic insulin sensitivity while inducing obesity (Dentin et al. 2012; Herman et al. 2012 ).
In our results, although there is less responsiveness to insulin in glucose metabolization in the adipocytes of middle-aged rats, the lipogenic process remains intense even without insulin stimulation, particularly in the PE region cells, which may compensate for the low response to the hormone and contribute to cellular hypertrophy of the intra-abdominal adipocytes, even in a manner not associated with insulin activity. Other substrates (oleic acid and lactate) used to evaluate lipogenesis by their incorporation into triglycerides also showed a more robust response, with greater evidence in the PE cells, indicating that both glyceroneogenesis and fatty acid esterification capabilities were elevated. Taking together, these results corroborated the idea that incorporation of energetic substrates in adipose tissue increases when metabolic dysfunctions are developing and might be adaptations which maintain systemic metabolic homeostasis. Along this line of reasoning, the percentage of de novo lipogenesis also increased in SC tissue adipocytes, a metabolic pathway recently proposed as one of the main factors of systemic sensitivity to insulin, because synthesis of fatty acids from glucose is a determinant of the adipose tissue's contributions to this process (Abel et al. 2001; Herman et al. 2012) . Therefore, the metabolic adaptations presented in our model (a greater capacity for esterification, glyceroneogenesis, and basal glucose incorporation) may be responsible for plugging the excess substrates potentially present in the blood stream (such as glucose due to glucose intolerance and fatty acids due to greater lipolysis).
On the other hand, although these metabolic adaptations of adipose cells may, at a certain point, contribute to stable fasting glycemia and insulinemia, as presented in our model, we know that the continuous increase of adipose mass, particularly through hypertrophy of the adipocytes, may result in obesity associated with metabolic syndromes. Thus, despite the existence of metabolically healthy obese people, prospective studies show that with time, these individuals have a greater risk for developing diseases such as diabetes (Soriguer et al. 2013) . In this sense, we notice that in our model, it is already possible to verify glucose intolerance after oral glucose challenge.
Furthermore, the significant increase in adipocyte volume, but no increase in the number of adipose cells, is characteristic of the aging process, in which the differentiation of pre-adipocytes and, therefore, the reconstitution of new cells, are reduced. This is accompanied by cellular dysfunction of the mature adipocytes that, given their tendency toward hypertrophy, begin to activate the cellular stress pathways, inflammation, and apoptosis (Kirkland et al. 2002; Kirkland and Dobson 1997) . This may have a direct relationship with an increase in the metabolic syndrome components found in aging, since the surgical removal of intra-abdominal fat restores systemic and hepatic insulin sensitivity in aged animals and decreases the expression of proinflammatory cytokines, such as TNF alpha, in subcutaneous adipose tissue (Gabriely et al. 2002) . It is also known that metabolically functional obese individuals (that is, without insulin resistance) have a heightened distribution of subcutaneous fat (Klöting et al. 2010 ). This does not seem to occur in our model, in which fat from the intra-abdominal cavity is preferentially more developed and metabolically active.
Conclusion
We concluded that adipocyte metabolism of middleaged animals seems to strongly favor cellular hypertrophy and increased adipose mass, particularly the intra-abdominal fat pad PE. As we showed, these changes in the metabolic handling of substrates may be comprehended as a metabolic adaptation taking place in the adipose tissue to avoid the spreading of fat that can reach tissues beyond adipose protecting them against ectopic fat accumulation that evolve to lipotoxicity, a potentially harmful event to the cells. However, these adaptations may have the potential to lead to future metabolic dysfunctions seen in the senescence.
